Strom Stephen C, Bruzzone Paolo, Cai Hongbo, Ellis Ewa, Lehmann Thomas, Mitamura Keitaro, Miki Toshio
Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Cell Transplant. 2006;15 Suppl 1:S105-10. doi: 10.3727/000000006783982395.
Hepatocyte transplantation has been proposed as a method to support patients with liver insufficiency. There are three main areas where the transplantation of isolated hepatocytes has been proposed and used for clinical therapy. Cell transplantation has been used: 1) for temporary metabolic support of patients in end-stage liver failure awaiting whole organ transplantation, 2) as a method to support liver function and facilitate regeneration of the native liver in cases of fulminant hepatic failure, and 3) in a manner similar to gene therapy, as a "cellular therapy" for patients with genetic defects in vital liver functions. We will briefly review the basic research that leads to clinical hepatocyte transplantation, the published clinical experience with this experimental technique, and some possible future uses of hepatocyte transplantation.
肝细胞移植已被提议作为一种支持肝功能不全患者的方法。孤立肝细胞移植已被提议并用于临床治疗的主要有三个领域。细胞移植已被用于:1)为等待全器官移植的终末期肝衰竭患者提供临时代谢支持;2)作为支持肝功能并促进暴发性肝衰竭病例中天然肝脏再生的一种方法;3)以类似于基因治疗的方式,作为对重要肝功能存在遗传缺陷患者的“细胞疗法”。我们将简要回顾促成临床肝细胞移植的基础研究、该实验技术已发表的临床经验以及肝细胞移植未来一些可能的用途。